Share Price and Basic Stock Data
Last Updated: February 25, 2025, 4:44 am
PEG Ratio | 0.70 |
---|
Competitors of IFGL Refractories Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Morganite Crucible (India) Ltd | 763 Cr. | 1,363 | 1,964/1,251 | 27.9 | 246 | 2.94 % | 28.3 % | 20.2 % | 5.00 |
Associated Ceramics Ltd | 64.5 Cr. | 215 | 1,408/198 | 45.1 | 75.6 | 0.00 % | 5.69 % | 4.09 % | 10.0 |
Vesuvius India Ltd | 8,189 Cr. | 4,034 | 6,000/3,012 | 31.3 | 642 | 0.32 % | 26.1 % | 19.4 % | 10.0 |
IFGL Refractories Ltd | 1,380 Cr. | 383 | 755/326 | 29.3 | 306 | 1.83 % | 8.97 % | 7.82 % | 10.0 |
Industry Average | 3,444.00 Cr | 1,498.75 | 33.40 | 317.40 | 1.27% | 17.27% | 12.88% | 8.75 |
Quarterly Result
Metric | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 246 | 289 | 284 | 275 | 310 | 314 | 361 | 359 | 343 | 316 | 368 | 424 | 456 |
Expenses | 207 | 240 | 239 | 242 | 273 | 278 | 324 | 325 | 307 | 282 | 320 | 368 | 388 |
Operating Profit | 39 | 49 | 44 | 33 | 37 | 36 | 37 | 34 | 36 | 34 | 48 | 56 | 68 |
OPM % | 16% | 17% | 16% | 12% | 12% | 11% | 10% | 9% | 11% | 11% | 13% | 13% | 15% |
Other Income | 2 | 11 | 4 | 3 | 4 | 4 | 5 | 0 | 3 | 2 | 8 | 3 | 4 |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 2 |
Depreciation | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 13 | 13 | 13 | 16 | 16 | 16 |
Profit before tax | 28 | 47 | 35 | 23 | 28 | 26 | 27 | 20 | 24 | 22 | 40 | 41 | 54 |
Tax % | 26% | 21% | 107% | 22% | 28% | 27% | 24% | 28% | 19% | 28% | 26% | 28% | 29% |
Net Profit | 21 | 37 | -3 | 18 | 20 | 19 | 21 | 15 | 19 | 16 | 29 | 30 | 38 |
EPS in Rs | 5.73 | 10.34 | -0.70 | 4.96 | 5.55 | 5.24 | 5.74 | 4.04 | 5.40 | 4.38 | 8.16 | 8.22 | 10.54 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|
Sales | 766 | 835 | 950 | 917 | 1,022 | 1,260 | 1,386 | 1,563 |
Expenses | 667 | 729 | 841 | 825 | 865 | 1,117 | 1,233 | 1,357 |
Operating Profit | 99 | 106 | 109 | 92 | 157 | 143 | 153 | 206 |
OPM % | 13% | 13% | 12% | 10% | 15% | 11% | 11% | 13% |
Other Income | 4 | 4 | 4 | -10 | 19 | 16 | 13 | 17 |
Interest | 5 | 4 | 4 | 4 | 3 | 3 | 5 | 7 |
Depreciation | 44 | 44 | 46 | 48 | 49 | 51 | 56 | 60 |
Profit before tax | 55 | 63 | 64 | 30 | 124 | 104 | 106 | 157 |
Tax % | 8% | 25% | 21% | 35% | 47% | 25% | 25% | |
Net Profit | 50 | 47 | 50 | 19 | 66 | 77 | 79 | 113 |
EPS in Rs | 171.36 | 13.07 | 14.00 | 5.40 | 18.20 | 21.50 | 21.98 | 31.30 |
Dividend Payout % | 1% | 15% | 18% | 46% | 55% | 33% | 32% |
YoY Net Profit Growth
Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -6.00% | 6.38% | -62.00% | 247.37% | 16.67% | 2.60% |
Change in YoY Net Profit Growth (%) | 0.00% | 12.38% | -68.38% | 309.37% | -230.70% | -14.07% |
IFGL Refractories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2017-2018 to 2022-2023.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 17% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 7% |
TTM: | -52% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 14% |
1 Year: | -33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 8% |
Last Year: | 8% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 11:32 pm
Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 |
Reserves | 650 | 716 | 759 | 773 | 854 | 898 | 969 | 1,036 | 1,068 |
Borrowings | 84 | 112 | 89 | 65 | 64 | 99 | 160 | 174 | 189 |
Other Liabilities | 158 | 134 | 135 | 150 | 230 | 253 | 261 | 244 | 255 |
Total Liabilities | 894 | 999 | 1,019 | 1,024 | 1,184 | 1,286 | 1,426 | 1,490 | 1,547 |
Fixed Assets | 471 | 461 | 454 | 440 | 416 | 422 | 500 | 517 | 572 |
CWIP | 2 | 8 | 6 | 7 | 22 | 25 | 46 | 104 | 67 |
Investments | 12 | 13 | 46 | 94 | 128 | 135 | 132 | 126 | 110 |
Other Assets | 409 | 516 | 513 | 483 | 618 | 704 | 748 | 743 | 798 |
Total Assets | 894 | 999 | 1,019 | 1,024 | 1,184 | 1,286 | 1,426 | 1,490 | 1,547 |
Cash Flow
Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Free Cash Flow | 15.00 | -6.00 | 20.00 | 27.00 | 93.00 | 44.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
Debtor Days | 109 | 124 | 88 | 84 | 82 | 79 | 92 | 72 |
Inventory Days | 94 | 94 | 120 | 113 | 129 | 154 | 153 | 132 |
Days Payable | 118 | 109 | 95 | 99 | 119 | 111 | 94 | 79 |
Cash Conversion Cycle | 85 | 110 | 112 | 98 | 91 | 122 | 151 | 126 |
Working Capital Days | 97 | 120 | 102 | 87 | 83 | 103 | 120 | 99 |
ROCE % | 8% | 8% | 6% | 14% | 11% | 10% | 9% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
HDFC Small Cap Fund - Regular Plan | 2,752,036 | 0.58 | 135.06 | 2,752,036 | 2025-02-22 | 0% |
Aditya Birla Sun Life Small Cap Fund | 500,403 | 0.54 | 24.56 | 2,752,036 | 2025-02-22 | -81.82% |
DSP Tiger Fund | 472,408 | 0.94 | 23.18 | 2,752,036 | 2025-02-22 | -82.83% |
Aditya Birla Sun Life Balanced Advantage Fund | 324,686 | 0.24 | 15.93 | 2,752,036 | 2025-02-22 | -88.2% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 22.66 | 21.98 | 21.50 | 18.20 | 5.40 |
Diluted EPS (Rs.) | 22.66 | 21.98 | 21.50 | 18.20 | 5.40 |
Cash EPS (Rs.) | 40.50 | 37.39 | 35.69 | 31.68 | 18.81 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 297.47 | 278.87 | 259.17 | 247.09 | 224.46 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 297.47 | 278.87 | 259.17 | 247.09 | 224.46 |
Revenue From Operations / Share (Rs.) | 454.92 | 384.72 | 349.48 | 283.56 | 254.54 |
PBDIT / Share (Rs.) | 48.04 | 46.09 | 43.98 | 48.80 | 28.45 |
PBIT / Share (Rs.) | 30.21 | 30.67 | 29.79 | 35.32 | 15.04 |
PBT / Share (Rs.) | 27.15 | 29.33 | 28.84 | 34.47 | 8.31 |
Net Profit / Share (Rs.) | 22.66 | 21.98 | 21.50 | 18.20 | 5.40 |
NP After MI And SOA / Share (Rs.) | 22.66 | 21.98 | 21.50 | 18.20 | 5.40 |
PBDIT Margin (%) | 10.56 | 11.97 | 12.58 | 17.20 | 11.17 |
PBIT Margin (%) | 6.64 | 7.97 | 8.52 | 12.45 | 5.90 |
PBT Margin (%) | 5.96 | 7.62 | 8.25 | 12.15 | 3.26 |
Net Profit Margin (%) | 4.98 | 5.71 | 6.15 | 6.41 | 2.12 |
NP After MI And SOA Margin (%) | 4.98 | 5.71 | 6.15 | 6.41 | 2.12 |
Return on Networth / Equity (%) | 7.61 | 7.88 | 8.29 | 7.36 | 2.40 |
Return on Capital Employeed (%) | 9.24 | 9.89 | 10.72 | 13.28 | 6.41 |
Return On Assets (%) | 5.48 | 5.55 | 6.02 | 5.54 | 1.89 |
Long Term Debt / Equity (X) | 0.05 | 0.04 | 0.01 | 0.01 | 0.01 |
Total Debt / Equity (X) | 0.15 | 0.14 | 0.09 | 0.05 | 0.06 |
Asset Turnover Ratio (%) | 1.12 | 0.77 | 0.78 | 0.72 | 0.60 |
Current Ratio (X) | 2.68 | 2.71 | 2.82 | 3.22 | 3.09 |
Quick Ratio (X) | 1.72 | 1.73 | 1.91 | 2.48 | 2.32 |
Inventory Turnover Ratio (X) | 2.46 | 1.73 | 2.16 | 2.09 | 1.83 |
Dividend Payout Ratio (NP) (%) | 30.88 | 31.85 | 46.51 | 0.00 | 92.61 |
Dividend Payout Ratio (CP) (%) | 17.28 | 18.72 | 28.01 | 0.00 | 26.57 |
Earning Retention Ratio (%) | 69.12 | 68.15 | 53.49 | 0.00 | 7.39 |
Cash Earning Retention Ratio (%) | 82.72 | 81.28 | 71.99 | 0.00 | 73.43 |
Interest Coverage Ratio (X) | 15.69 | 34.31 | 46.51 | 57.50 | 28.39 |
Interest Coverage Ratio (Post Tax) (X) | 8.40 | 17.36 | 23.74 | 22.44 | 12.09 |
Enterprise Value (Cr.) | 2039.82 | 846.60 | 886.69 | 997.58 | 272.29 |
EV / Net Operating Revenue (X) | 1.24 | 0.61 | 0.70 | 0.97 | 0.29 |
EV / EBITDA (X) | 11.78 | 5.10 | 5.59 | 5.67 | 2.66 |
MarketCap / Net Operating Revenue (X) | 1.19 | 0.54 | 0.73 | 1.12 | 0.36 |
Retention Ratios (%) | 69.11 | 68.14 | 53.48 | 0.00 | 7.38 |
Price / BV (X) | 1.82 | 0.75 | 0.99 | 1.28 | 0.41 |
Price / Net Operating Revenue (X) | 1.19 | 0.54 | 0.73 | 1.12 | 0.36 |
EarningsYield | 0.04 | 0.10 | 0.08 | 0.05 | 0.05 |
After reviewing the key financial ratios for IFGL Refractories Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 22.66. This value is within the healthy range. It has increased from 21.98 (Mar 23) to 22.66, marking an increase of 0.68.
- For Diluted EPS (Rs.), as of Mar 24, the value is 22.66. This value is within the healthy range. It has increased from 21.98 (Mar 23) to 22.66, marking an increase of 0.68.
- For Cash EPS (Rs.), as of Mar 24, the value is 40.50. This value is within the healthy range. It has increased from 37.39 (Mar 23) to 40.50, marking an increase of 3.11.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 297.47. It has increased from 278.87 (Mar 23) to 297.47, marking an increase of 18.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 297.47. It has increased from 278.87 (Mar 23) to 297.47, marking an increase of 18.60.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 454.92. It has increased from 384.72 (Mar 23) to 454.92, marking an increase of 70.20.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 48.04. This value is within the healthy range. It has increased from 46.09 (Mar 23) to 48.04, marking an increase of 1.95.
- For PBIT / Share (Rs.), as of Mar 24, the value is 30.21. This value is within the healthy range. It has decreased from 30.67 (Mar 23) to 30.21, marking a decrease of 0.46.
- For PBT / Share (Rs.), as of Mar 24, the value is 27.15. This value is within the healthy range. It has decreased from 29.33 (Mar 23) to 27.15, marking a decrease of 2.18.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 22.66. This value is within the healthy range. It has increased from 21.98 (Mar 23) to 22.66, marking an increase of 0.68.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 22.66. This value is within the healthy range. It has increased from 21.98 (Mar 23) to 22.66, marking an increase of 0.68.
- For PBDIT Margin (%), as of Mar 24, the value is 10.56. This value is within the healthy range. It has decreased from 11.97 (Mar 23) to 10.56, marking a decrease of 1.41.
- For PBIT Margin (%), as of Mar 24, the value is 6.64. This value is below the healthy minimum of 10. It has decreased from 7.97 (Mar 23) to 6.64, marking a decrease of 1.33.
- For PBT Margin (%), as of Mar 24, the value is 5.96. This value is below the healthy minimum of 10. It has decreased from 7.62 (Mar 23) to 5.96, marking a decrease of 1.66.
- For Net Profit Margin (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 23) to 4.98, marking a decrease of 0.73.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 8. It has decreased from 5.71 (Mar 23) to 4.98, marking a decrease of 0.73.
- For Return on Networth / Equity (%), as of Mar 24, the value is 7.61. This value is below the healthy minimum of 15. It has decreased from 7.88 (Mar 23) to 7.61, marking a decrease of 0.27.
- For Return on Capital Employeed (%), as of Mar 24, the value is 9.24. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 23) to 9.24, marking a decrease of 0.65.
- For Return On Assets (%), as of Mar 24, the value is 5.48. This value is within the healthy range. It has decreased from 5.55 (Mar 23) to 5.48, marking a decrease of 0.07.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 23) to 0.05, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.15. This value is within the healthy range. It has increased from 0.14 (Mar 23) to 0.15, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has increased from 0.77 (Mar 23) to 1.12, marking an increase of 0.35.
- For Current Ratio (X), as of Mar 24, the value is 2.68. This value is within the healthy range. It has decreased from 2.71 (Mar 23) to 2.68, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 24, the value is 1.72. This value is within the healthy range. It has decreased from 1.73 (Mar 23) to 1.72, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.46. This value is below the healthy minimum of 4. It has increased from 1.73 (Mar 23) to 2.46, marking an increase of 0.73.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 30.88. This value is within the healthy range. It has decreased from 31.85 (Mar 23) to 30.88, marking a decrease of 0.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 17.28. This value is below the healthy minimum of 20. It has decreased from 18.72 (Mar 23) to 17.28, marking a decrease of 1.44.
- For Earning Retention Ratio (%), as of Mar 24, the value is 69.12. This value is within the healthy range. It has increased from 68.15 (Mar 23) to 69.12, marking an increase of 0.97.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 82.72. This value exceeds the healthy maximum of 70. It has increased from 81.28 (Mar 23) to 82.72, marking an increase of 1.44.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 15.69. This value is within the healthy range. It has decreased from 34.31 (Mar 23) to 15.69, marking a decrease of 18.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 8.40. This value is within the healthy range. It has decreased from 17.36 (Mar 23) to 8.40, marking a decrease of 8.96.
- For Enterprise Value (Cr.), as of Mar 24, the value is 2,039.82. It has increased from 846.60 (Mar 23) to 2,039.82, marking an increase of 1,193.22.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.24. This value is within the healthy range. It has increased from 0.61 (Mar 23) to 1.24, marking an increase of 0.63.
- For EV / EBITDA (X), as of Mar 24, the value is 11.78. This value is within the healthy range. It has increased from 5.10 (Mar 23) to 11.78, marking an increase of 6.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.19. This value is within the healthy range. It has increased from 0.54 (Mar 23) to 1.19, marking an increase of 0.65.
- For Retention Ratios (%), as of Mar 24, the value is 69.11. This value is within the healthy range. It has increased from 68.14 (Mar 23) to 69.11, marking an increase of 0.97.
- For Price / BV (X), as of Mar 24, the value is 1.82. This value is within the healthy range. It has increased from 0.75 (Mar 23) to 1.82, marking an increase of 1.07.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.19. This value is within the healthy range. It has increased from 0.54 (Mar 23) to 1.19, marking an increase of 0.65.
- For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.04, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in IFGL Refractories Ltd:
- Net Profit Margin: 4.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.24% (Industry Average ROCE: 17.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.61% (Industry Average ROE: 12.88%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.3 (Industry average Stock P/E: 33.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.15
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.98%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Refractories | Sector 'B', Sundargarh Dist. Orissa 770031 | ifgl.works@ifgl.in http://www.ifglref.com |
Management | |
---|---|
Name | Position Held |
Mr. Shishir Kumar Bajoria | Chairman |
Mr. James McIntosh | Managing Director |
Mr. Arasu Shanmugam | Director & CEO |
Mr. Rajesh Agarwal | Director |
Mr. D G Rajan | Independent Director |
Mr. Debal Kumar Banerji | Independent Director |
Mr. Sudhamoy Khasnobis | Independent Director |
Mr. Gaurav Swarup | Independent Director |
Ms. Anita Gupta | Independent Director |
FAQ
What is the latest intrinsic value of IFGL Refractories Ltd?
Let's break down IFGL Refractories Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 25 February 2025:
- Calculated Fair Value: ₹571.16
- Current Market Price: ₹383.00
- Variance: 49.13% higher
This suggests IFGL Refractories Ltd is currently undervalued by 49.13%. For context:
- Market Cap: 1,380 Cr.
- 52-Week Range: 755/326
- Reserves (Sep 2024): ₹1,068 Cr
- Liabilities: 1,547 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of IFGL Refractories Ltd?
The Market Cap of IFGL Refractories Ltd is 1,380 Cr..
What is the current Stock Price of IFGL Refractories Ltd as on 25 February 2025?
The current stock price of IFGL Refractories Ltd as on 25 February 2025 is ₹383.
What is the High / Low of IFGL Refractories Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of IFGL Refractories Ltd stocks is 755/326.
What is the Stock P/E of IFGL Refractories Ltd?
The Stock P/E of IFGL Refractories Ltd is 29.3.
What is the Book Value of IFGL Refractories Ltd?
The Book Value of IFGL Refractories Ltd is 306.
What is the Dividend Yield of IFGL Refractories Ltd?
The Dividend Yield of IFGL Refractories Ltd is 1.83 %.
What is the ROCE of IFGL Refractories Ltd?
The ROCE of IFGL Refractories Ltd is 8.97 %.
What is the ROE of IFGL Refractories Ltd?
The ROE of IFGL Refractories Ltd is 7.82 %.
What is the Face Value of IFGL Refractories Ltd?
The Face Value of IFGL Refractories Ltd is 10.0.